文献速递产科母胎医学

低危单次剖宫产史患者引产与期待治疗的比较

Induction of labor vs expectant management among low-risk patients with 1 prior cesarean delivery.
PubMed 文献 · Am J Obstet Gynecol · 2024-06-07

这项横断面研究分析2016至2021年美国生命统计出生证明数据,纳入198,797例低危、单次剖宫产史、单胎头位孕妇,比较39周引产与期待治疗至40至42周分娩的结局。调整分析显示39周引产者阴道分娩率更高(38.0% vs 31.8%;调整风险比1.32,95%CI 1.28,1.36),母体和新生儿并发症复合结局无显著差异。

要点

  • 39周引产者阴道分娩率38.0%,期待治疗者31.8%,调整风险比1.32(95%CI 1.28,1.36)。
  • 阴道分娩者中引产与手术阴道分娩风险升高相关(11.1% vs 10.0%;调整风险比1.15,95%CI 1.07,1.24)。
  • 母体并发症复合结局两组均为0.9%(调整风险比0.92,95%CI 0.79,1.06),新生儿并发症复合结局7.3% vs 6.7%(调整风险比1.04,95%CI 0.98,1.09),均无显著差异。

核心结论

  • 与期待治疗相比,低危单次剖宫产史患者39周择期引产与阴道分娩可能性显著更高相关,母体和新生儿并发症复合结局无差异。
  • 作者指出需要前瞻性研究以更好地阐明该人群引产的风险和获益。

研究设计与样本

  • 横断面研究,分析2016至2021年美国生命统计出生证明数据。
  • 纳入头位、单胎妊娠、单次剖宫产史者;排除既往阴道分娩、分娩早于39周0天或晚于42周6天、以及有内科合并症者。
  • 主要暴露为39周0天至39周6天引产,对照为期待治疗并于40周0天至42周6天分娩。
  • 主要结局为阴道分娩;次要结局为母体和新生儿并发症复合结局。
  • 采用未调整和调整的对数二项回归模型,结果以风险比及95%置信区间表示。

主要发现

  • 共纳入198,797例,其中25,915例(13.0%)在39周0天至39周6天引产,172,882例(87.0%)期待治疗并于40周0天至42周6天分娩。
  • 调整分析中,39周引产者阴道分娩率38.0%,期待治疗者31.8%(调整风险比1.32,95%CI 1.28,1.36)。
  • 阴道分娩者中,引产与手术阴道分娩可能性增加相关(11.1% vs 10.0%;调整风险比1.15,95%CI 1.07,1.24)。
  • 母体并发症复合结局两组均为0.9%(调整风险比0.92,95%CI 0.79,1.06);子宫破裂率0.3%,围产期子宫切除术0.04% vs 0.05%,ICU入住0.1% vs 0.2%,组间均无显著差异。
  • 新生儿并发症复合结局引产组7.3% vs 期待治疗组6.7%(调整风险比1.04,95%CI 0.98,1.09),无显著差异。

关键数值与推荐

  • 主要暴露:39周0天至39周6天引产;对照:期待治疗并于40周0天至42周6天分娩。
  • 主要结局阴道分娩:引产组38.0% vs 期待治疗组31.8%,调整风险比1.32(95%CI 1.28,1.36)。
  • 手术阴道分娩(限于阴道分娩者):引产组11.1% vs 期待治疗组10.0%,调整风险比1.15(95%CI 1.07,1.24)。
  • 母体并发症复合结局:两组均为0.9%,调整风险比0.92(95%CI 0.79,1.06)。
  • 新生儿并发症复合结局:引产组7.3% vs 期待治疗组6.7%,调整风险比1.04(95%CI 0.98,1.09)。

临床怎么用

  • 原文未据此给出推荐。
  • 作者结论指出,低危单次剖宫产史患者39周择期引产与阴道分娩可能性更高相关,母体和新生儿并发症复合结局无差异。
  • 作者指出需要前瞻性研究以更好地阐明该人群引产的风险和获益。

局限性

  • 原文未报告局限性。
  • 作者在结论中提出需要前瞻性研究以更好地阐明该人群引产的风险和获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies that have compared induction of labor in individuals with 1 prior cesarean delivery to expectant management have shown conflicting results. OBJECTIVE: To determine the association between clinical outcomes and induction of labor at 39 weeks in a national sample of otherwise low-risk patients with 1 prior cesarean delivery. STUDY DESIGN: This cross-sectional study analyzed 2016 to 2021 US Vital Statistics birth certificate data. Individuals with vertex, singleton pregnancies, and 1 prior cesarean delivery were included. Patients with prior vaginal deliveries, delivery before 39 weeks 0 days or after 42 weeks 6 days of gestation, and medical comorbidities were excluded. The primary exposure of interest was induction of labor at 39 weeks 0 days to 39 weeks 6 days compared to expectant management with delivery from 40 weeks 0 days to 42 weeks 6 days. The primary outcome was vaginal delivery. The main secondary outcomes were separate maternal and neonatal morbidity composites. The maternal morbidity composite included uterine rupture, operative vaginal delivery, peripartum hysterectomy, intensive care unit admission, and transfusion. The neonatal morbidity composite included neonatal intensive care unit admission, Apgar score less than 5 at 5 minutes, immediate ventilation, prolonged ventilation, and seizure or serious neurological dysfunction. Unadjusted and adjusted log binomial regression models accounting for demographic variables and the exposure of interest (induction vs expectant management) were performed. Results are presented as unadjusted and adjusted risk ratios with 95% confidence intervals. RESULTS: From 2016 to 2021, a total of 198,797 individuals with vertex, singleton pregnancies, and 1 prior cesarean were included in the primary analysis. Of these individuals, 25,915 (13.0%) underwent induction of labor from 39 weeks 0 days to 39 weeks 6 days and 172,882 (87.0%) were expectantly managed with deliveries between 40 weeks 0 days and 42 weeks 6 days. In adjusted analyses, patients induced at 39 weeks were more likely to have a vaginal delivery when compared to those expectantly managed (38.0% vs 31.8%; adjusted risk ratio 1.32, 95% confidence interval 1.28, 1.36). Among those who had vaginal deliveries, induction of labor was associated with increased likelihood of operative vaginal delivery (11.1% vs 10.0; adjusted risk ratio 1.15, 95% confidence interval 1.07, 1.24). The maternal morbidity composite occurred in 0.9% of individuals in both the induction and expectant management groups (adjusted risk ratio 0.92, 95% confidence interval 0.79, 1.06). The rates of uterine rupture (0.3%), peripartum hysterectomy (0.04% vs 0.05%), and intensive care unit admission (0.1% vs 0.2%) were all relatively low and did not differ significantly between groups. There was also no significant difference in the neonatal morbidity composite between the induction and expectant management groups (7.3% vs 6.7%; adjusted risk ratio 1.04, 95% confidence interval 0.98, 1.09). CONCLUSION: When compared to expectant management, elective induction of labor at 39 weeks in low-risk patients with 1 prior cesarean delivery was associated with a significantly higher likelihood of vaginal delivery with no difference in composite maternal and neonatal morbidity outcomes. Prospective studies are needed to better elucidate the risks and benefits of induction of labor in this patient population.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Ukoha EP, Wen T, Reddy UM, et al. Induction of labor vs expectant management among low-risk patients with 1 prior cesarean delivery. Am J Obstet Gynecol. 2024. PMID: 38852849. doi:10.1016/j.ajog.2024.06.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。